JPS5668674A - 5-fluorouracil derivative - Google Patents
5-fluorouracil derivativeInfo
- Publication number
- JPS5668674A JPS5668674A JP14513179A JP14513179A JPS5668674A JP S5668674 A JPS5668674 A JP S5668674A JP 14513179 A JP14513179 A JP 14513179A JP 14513179 A JP14513179 A JP 14513179A JP S5668674 A JPS5668674 A JP S5668674A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- reacted
- fluorouracil
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical class FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 8
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 abstract 2
- IBEQUECTIJCIRA-UHFFFAOYSA-N [(5-fluoro-2,4-dioxopyrimidin-1-yl)-phenylmethoxy]methyl 2,2-dimethylpropanoate Chemical compound C1=C(F)C(=O)NC(=O)N1C(OCOC(=O)C(C)(C)C)C1=CC=CC=C1 IBEQUECTIJCIRA-UHFFFAOYSA-N 0.000 abstract 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 abstract 1
- 150000001299 aldehydes Chemical class 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- -1 alkali metal salt Chemical class 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910000039 hydrogen halide Inorganic materials 0.000 abstract 1
- 239000012433 hydrogen halide Substances 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14513179A JPS5668674A (en) | 1979-11-08 | 1979-11-08 | 5-fluorouracil derivative |
| US06/203,363 US4336381A (en) | 1979-11-08 | 1980-11-03 | 5-Fluorouracil derivatives |
| GB8035655A GB2063257A (en) | 1979-11-08 | 1980-11-06 | 5-fluorouracil derivatives |
| AU64166/80A AU6416680A (en) | 1979-11-08 | 1980-11-07 | 5-fluorouracil derivatives |
| DE19803042120 DE3042120A1 (de) | 1979-11-08 | 1980-11-07 | 5-fluoruracil-derivate |
| FR8023915A FR2469406A1 (fr) | 1979-11-08 | 1980-11-07 | Derives de 5-fluorouracile administrables par voie orale, efficaces contre les tumeurs malignes |
| IT8068717A IT8068717A0 (it) | 1979-11-08 | 1980-11-10 | Azione antitumorale derivati del 5 fluorouracile ad |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14513179A JPS5668674A (en) | 1979-11-08 | 1979-11-08 | 5-fluorouracil derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5668674A true JPS5668674A (en) | 1981-06-09 |
Family
ID=15378115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14513179A Pending JPS5668674A (en) | 1979-11-08 | 1979-11-08 | 5-fluorouracil derivative |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4336381A (ja) |
| JP (1) | JPS5668674A (ja) |
| AU (1) | AU6416680A (ja) |
| DE (1) | DE3042120A1 (ja) |
| FR (1) | FR2469406A1 (ja) |
| GB (1) | GB2063257A (ja) |
| IT (1) | IT8068717A0 (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04312337A (ja) * | 1991-04-12 | 1992-11-04 | Mitsubishi Electric Corp | モールドモータ |
| JP2005513156A (ja) * | 2001-12-31 | 2005-05-12 | ファエンドォラー，ハンス，ロドルフ | 抗新生物薬における長鎖脂肪アルコール置換基 |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119202B1 (en) * | 1989-02-08 | 2006-10-10 | Glaxo Wellcome Inc. | Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties |
| US6903224B2 (en) | 1988-04-11 | 2005-06-07 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes |
| US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| US5270315A (en) * | 1988-04-11 | 1993-12-14 | Biochem Pharma Inc. | 4-(purinyl bases)-substituted-1,3-dioxlanes |
| US6350753B1 (en) | 1988-04-11 | 2002-02-26 | Biochem Pharma Inc. | 2-Substituted-4-substituted-1,3-dioxolanes and use thereof |
| US5041449A (en) * | 1988-04-11 | 1991-08-20 | Iaf Biochem International, Inc. | 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections |
| UA45942A (uk) * | 1989-02-08 | 2002-05-15 | Біокем Фарма, Інк. | 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція |
| US6642245B1 (en) * | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
| US6703396B1 (en) | 1990-02-01 | 2004-03-09 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
| US5728575A (en) * | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
| GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
| US5587480A (en) * | 1990-11-13 | 1996-12-24 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
| US6369066B1 (en) | 1990-11-13 | 2002-04-09 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
| US6228860B1 (en) | 1990-11-13 | 2001-05-08 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
| US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
| US5925643A (en) * | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
| US5817667A (en) * | 1991-04-17 | 1998-10-06 | University Of Georgia Research Foudation | Compounds and methods for the treatment of cancer |
| GB9116601D0 (en) * | 1991-08-01 | 1991-09-18 | Iaf Biochem Int | 1,3-oxathiolane nucleoside analogues |
| US20050192299A1 (en) * | 1992-04-16 | 2005-09-01 | Yung-Chi Cheng | Method of treating or preventing hepatitis B virus |
| WO1995007086A1 (en) | 1993-09-10 | 1995-03-16 | Emory University | Nucleosides with anti-hepatitis b virus activity |
| US20020120130A1 (en) * | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
| US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
| IL115156A (en) * | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
| US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
| US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
| US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
| EP0831852B1 (en) * | 1995-06-07 | 2006-11-29 | Emory University | Nucleosides with anti-hepatitis b virus activity |
| US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
| MXPA00008348A (es) * | 1998-02-25 | 2005-07-15 | Univ Emory | 2-fluronucleosidos. |
| DK1140937T3 (da) * | 1998-12-23 | 2004-03-22 | Shire Biochem Inc | Antivirale nucleosid-analoger |
| US6436948B1 (en) | 2000-03-03 | 2002-08-20 | University Of Georgia Research Foundation Inc. | Method for the treatment of psoriasis and genital warts |
| EP1890537B1 (en) * | 2005-06-07 | 2012-08-08 | Yale University | Methods of treating cancer and other conditions or disease states using lfmau and ldt |
| WO2007011708A2 (en) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
| KR101406415B1 (ko) | 2005-07-15 | 2014-06-19 | 미셀 테크놀로지즈, 인코포레이티드 | 제어된 형태의 약물 분말을 함유하는 중합체 코팅 |
| US7951788B2 (en) * | 2005-12-02 | 2011-05-31 | Yale University | Method of treating cancer and other conditions or disease states using L-cytosine nucleoside analogs |
| US8895531B2 (en) * | 2006-03-23 | 2014-11-25 | Rfs Pharma Llc | 2′-fluoronucleoside phosphonates as antiviral agents |
| PL2019657T3 (pl) | 2006-04-26 | 2015-10-30 | Micell Technologies Inc | Powłoki zawierające wiele leków |
| US20080051464A1 (en) * | 2006-06-28 | 2008-02-28 | The Cleveland Clinic Foundation | Protein phosphatase inhibitors |
| WO2008002641A2 (en) * | 2006-06-28 | 2008-01-03 | The Cleveland Clinic Foundation | Protein phosphatase inhibitors |
| US9539593B2 (en) | 2006-10-23 | 2017-01-10 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
| JP5603598B2 (ja) | 2007-01-08 | 2014-10-08 | ミセル テクノロジーズ、インコーポレイテッド | 生物分解層を有するステント |
| US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
| AU2009251504B2 (en) | 2008-04-17 | 2013-09-05 | Micell Technologies, Inc. | Stents having bioabsorbable layers |
| CA2730995C (en) | 2008-07-17 | 2016-11-22 | Micell Technologies, Inc. | Drug delivery medical device |
| WO2011009096A1 (en) | 2009-07-16 | 2011-01-20 | Micell Technologies, Inc. | Drug delivery medical device |
| US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
| CA2756386C (en) | 2009-03-23 | 2019-01-15 | Micell Technologies, Inc. | Drug delivery medical device |
| JP2012522589A (ja) | 2009-04-01 | 2012-09-27 | ミシェル テクノロジーズ，インコーポレイテッド | 被覆ステント |
| CA2759015C (en) | 2009-04-17 | 2017-06-20 | James B. Mcclain | Stents having controlled elution |
| WO2011097103A1 (en) | 2010-02-02 | 2011-08-11 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
| US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
| CA2797110C (en) | 2010-04-22 | 2020-07-21 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
| CA2805631C (en) | 2010-07-16 | 2018-07-31 | Micell Technologies, Inc. | Drug delivery medical device |
| WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
| WO2013012689A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
| US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
| JP6330024B2 (ja) | 2013-03-12 | 2018-05-23 | マイセル・テクノロジーズ，インコーポレイテッド | 生体吸収性バイオメディカルインプラント |
| WO2014186532A1 (en) | 2013-05-15 | 2014-11-20 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
| WO2016033164A1 (en) | 2014-08-26 | 2016-03-03 | Enanta Pharmaceuticals, Inc. | Nucleoside and nucleotide derivatives |
| CN115850190B (zh) * | 2023-01-10 | 2024-09-10 | 四川大学 | 一种5-氟尿嘧啶衍生物及其抗肿瘤用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4124765A (en) * | 1975-05-13 | 1978-11-07 | Ono Pharmaceutical Co., Ltd. | 5-Fluorouracil derivatives |
| JPS5331676A (en) * | 1976-09-06 | 1978-03-25 | Mitsui Toatsu Chem Inc | Uracil derivatives and their preparation |
| CH633280A5 (de) * | 1978-03-09 | 1982-11-30 | Elkawi Ag | 5-fluoruracil-derivate und diese verbindungen enthaltende arzneimittel. |
-
1979
- 1979-11-08 JP JP14513179A patent/JPS5668674A/ja active Pending
-
1980
- 1980-11-03 US US06/203,363 patent/US4336381A/en not_active Expired - Lifetime
- 1980-11-06 GB GB8035655A patent/GB2063257A/en not_active Withdrawn
- 1980-11-07 FR FR8023915A patent/FR2469406A1/fr active Granted
- 1980-11-07 DE DE19803042120 patent/DE3042120A1/de not_active Withdrawn
- 1980-11-07 AU AU64166/80A patent/AU6416680A/en not_active Abandoned
- 1980-11-10 IT IT8068717A patent/IT8068717A0/it unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04312337A (ja) * | 1991-04-12 | 1992-11-04 | Mitsubishi Electric Corp | モールドモータ |
| JP2005513156A (ja) * | 2001-12-31 | 2005-05-12 | ファエンドォラー，ハンス，ロドルフ | 抗新生物薬における長鎖脂肪アルコール置換基 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2469406A1 (fr) | 1981-05-22 |
| AU6416680A (en) | 1981-05-14 |
| IT8068717A0 (it) | 1980-11-10 |
| FR2469406B1 (ja) | 1983-07-01 |
| DE3042120A1 (de) | 1981-08-27 |
| US4336381A (en) | 1982-06-22 |
| GB2063257A (en) | 1981-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5668674A (en) | 5-fluorouracil derivative | |
| ES485188A1 (es) | Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas | |
| JPS5690031A (en) | Preparation of aromatic aldehyde | |
| EP0047405A3 (en) | Azolylalkyl derivatives, process for their preparation and their use as fungicides | |
| HU903092D0 (en) | Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds | |
| JPS57156416A (en) | Platinum (2) complex and antitumor agent comprising it as active ingredient | |
| ES8101062A1 (es) | Procedimiento para la preparacion de nuevas ureas sustitui- das con radicales basicos. | |
| JPS5462324A (en) | Non-medical powdered agent | |
| JPS56158786A (en) | Novel camptothecin derivative and its preparation | |
| JPS5630927A (en) | Stabilization of guaiazulene and its derivative | |
| JPS57102867A (en) | Allantoin derivative and its preparation | |
| JPS5214721A (en) | Process for preparation of sodium malate hydrate | |
| JPS56118070A (en) | 1,3,8,9-tetraalkoxyphenanthridinium salt | |
| JPS5328123A (en) | Zinc compounds | |
| JPS57108017A (en) | Antithrombotic agent | |
| JPS5759848A (en) | Cyclohexanecarboxylic acid derivative | |
| JPS56128769A (en) | Amino-5-fluorouracil derivative and its preparation | |
| JPS55167274A (en) | Forphenicine derivative and its preparation | |
| JPS5793971A (en) | Preparation of piperazine derivative | |
| JPS57142952A (en) | 4-chloro-2-pentenamide derivative, its preparation and herbicide containing the same | |
| JPS5218830A (en) | Homoisotwistylamines antiviral agents for animals | |
| JPS56147757A (en) | Amino acid derivative | |
| JPS56118068A (en) | 3,8,9-trialkoxyphenanthridinium salt | |
| JPS5770860A (en) | Carboxylic acid derivative and its salt | |
| JPS53119822A (en) | Preparation of 2-dimethylaminoethylisothiocyanate |